Literature DB >> 21617912

Priority mental health disorders of children and adolescents in primary-care pediatric settings in India 2: diagnosis, pharmacological treatment and referral.

P S Russell1, M K C Nair, P Mammen, S R Shankar.   

Abstract

The advent of pediatric psychopharmacology has enormously improved psychiatric care of children and adolescents. Nonetheless, our practice of diagnosis, treatment and referral in primary-care pediatric settings is not optimum as current evidence based knowledge is not regularly applied in the actual clinical circumstances. To help primary-care pediatricians minimise this in research-clinical practice, pharmacological treatment and referral in their clinical practice, they need to follow a two-tier diagnostic and multi axial treatment approach. The two-tier diagnostic approach of using a screening measure followed by confirmation of the screen positive cases with reference standard clinical criterion, improves the sensitivity and specificity. The multiaxial treatment has the advantage of offering a holistic approach to the intervention and improve prognosis from the interacting axes. The primary-care physician should be aware of the medications of choice for the Priority Mental Health Disorders and their drug interactions. Finally, referral of cases with atypical presentations, multiple comorbidities and poor response to the first-line of treatment needs referral to the next tier in the system.

Entities:  

Mesh:

Year:  2011        PMID: 21617912     DOI: 10.1007/s12098-011-0427-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  22 in total

1.  Enhancing reviews of psychological treatments with pediatric populations: thoughts on next steps.

Authors:  Dennis Drotar
Journal:  J Pediatr Psychol       Date:  2002-03

2.  Use of the pediatric symptom checklist in strategies to improve preventive behavioral health care.

Authors:  M Navon; D Nelson; M Pagano; M Murphy
Journal:  Psychiatr Serv       Date:  2001-06       Impact factor: 3.084

Review 3.  Tricyclic and related drugs for nocturnal enuresis in children.

Authors:  C M A Glazener; J H C Evans; R E Peto
Journal:  Cochrane Database Syst Rev       Date:  2003

4.  A placebo-controlled trial of risperidone in Tourette syndrome.

Authors:  L Scahill; J F Leckman; R T Schultz; L Katsovich; B S Peterson
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

5.  Mental health in pediatric settings: distribution of disorders and factors related to service use.

Authors:  M J Briggs-Gowan; S M Horwitz; M E Schwab-Stone; J M Leventhal; P J Leaf
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-07       Impact factor: 8.829

6.  National trends in the treatment of attention deficit hyperactivity disorder.

Authors:  Mark Olfson; Marc J Gameroff; Steven C Marcus; Peter S Jensen
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

7.  A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.

Authors:  Linmarie Sikich; Robert M Hamer; Robert A Bashford; Brian B Sheitman; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2004-01       Impact factor: 7.853

Review 8.  Risperidone for autism spectrum disorder.

Authors:  O S Jesner; M Aref-Adib; E Coren
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

9.  Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

Authors:  Jackie Y W Cheng; Ronald Y L Chen; John S N Ko; Emil M L Ng
Journal:  Psychopharmacology (Berl)       Date:  2007-06-16       Impact factor: 4.415

10.  Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit.

Authors:  Jan N M Schieveld; Piet L J M Leroy; Jim van Os; Joost Nicolai; Gijs D Vos; Albert F G Leentjens
Journal:  Intensive Care Med       Date:  2007-04-25       Impact factor: 17.440

View more
  2 in total

1.  Perspectives in pediatric psychopharmacology.

Authors:  Darpan Kaur; Shaunak Ajinkya; Rakesh Ghildiyal; Daniel Joseph
Journal:  Indian J Psychol Med       Date:  2013-04

2.  Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.

Authors:  Manisha Juneja; Dennis Kobelt; Wolfgang Walther; Cynthia Voss; Janice Smith; Edgar Specker; Martin Neuenschwander; Björn-Oliver Gohlke; Mathias Dahlmann; Silke Radetzki; Robert Preissner; Jens Peter von Kries; Peter Michael Schlag; Ulrike Stein
Journal:  PLoS Biol       Date:  2017-06-01       Impact factor: 8.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.